Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puyu Shi

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cancer Letters|July 25, 2016
Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatmentPuyu Shi, You-Take Oh, Guojing Zhang, et al.
Epidemiology and Infection|September 30, 2020
Clinical characteristics of imported and second-generation coronavirus disease 2019 (COVID-19) cases in Shaanxi outside Wuhan, China: a multicentre retrospective studyPuyu Shi, Guoxia Ren, Jun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2017
Overcoming Acquired Resistance to AZD9291, A Third-Generation EGFR Inhibitor, through Modulation of MEK/ERK-Dependent Bim and Mcl-1 DegradationPuyu Shi, You-Take Oh, Liang Deng, et al.
The Lancet Regional Health. Western Pacific|September 9, 2025
Mental health literacy and the stigmatisation and discrimination of individuals affected by mental illnesses in China: a scoping reviewYamin Zhang, Meng Zhou, Rong Liang, et al.
Oncotarget|August 31, 2016
Blockade efficacy of MEK/ERK-dependent autophagy enhances PI3K/Akt inhibitor NVP-BKM120's therapeutic effectiveness in lung cancer cellsHui Ren, Hua Guo, Asmitananda Thakur, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cancer Letters|July 25, 2016
Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatmentPuyu Shi, You-Take Oh, Guojing Zhang, et al.
Epidemiology and Infection|September 30, 2020
Clinical characteristics of imported and second-generation coronavirus disease 2019 (COVID-19) cases in Shaanxi outside Wuhan, China: a multicentre retrospective studyPuyu Shi, Guoxia Ren, Jun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2017
Overcoming Acquired Resistance to AZD9291, A Third-Generation EGFR Inhibitor, through Modulation of MEK/ERK-Dependent Bim and Mcl-1 DegradationPuyu Shi, You-Take Oh, Liang Deng, et al.
The Lancet Regional Health. Western Pacific|September 9, 2025
Mental health literacy and the stigmatisation and discrimination of individuals affected by mental illnesses in China: a scoping reviewYamin Zhang, Meng Zhou, Rong Liang, et al.
Oncotarget|August 31, 2016
Blockade efficacy of MEK/ERK-dependent autophagy enhances PI3K/Akt inhibitor NVP-BKM120's therapeutic effectiveness in lung cancer cellsHui Ren, Hua Guo, Asmitananda Thakur, et al.
Pageof 4